BB BIOTECH AG - 19 Mar 2025 SCHEDULE 13G/A Report for Black Diamond Therapeutics, Inc. Common Stock (BDTX)

Filing Manager: BB BIOTECH AG
Reporting Manager: BB Biotech AG
Security: Black Diamond Therapeutics, Inc. Common Stock
Symbol: BDTX
Shares outstanding: 56.9M shares
Disclosed Ownership: 2.73M shares
Ownership: 4.8%
Form type: SCHEDULE 13G/A
Filing time: 21 Mar 2025, 13:01:32 UTC
Date of event: 19 Mar 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BB Biotech AG	4.8%	2.73M	0	2.73M	/s/ Martin Gubler	Martin Gubler/Signatory Authority
Biotech Growth N.V.	4.8%	2.73M	0	2.73M	/s/ Jan Bootsma	Jan Bootsma/Signatory Authority